Company news
Equillium, Inc. news in 2023
Equillium, Inc.'s news releases, calls and decks from 2023, newest first.
Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease
December 20, 2023
Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology
November 12, 2023
Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
November 7, 2023
Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology
November 5, 2023
Equillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of Rheumatology
October 18, 2023
Equillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics Symposium
October 15, 2023
Equillium to Host Analyst & Investor Day
October 2, 2023
Equillium to Present at the JonesTrading 2023 Healthcare Summit
October 1, 2023
Equillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event Conferences
September 19, 2023
Equillium to Attend Wells Fargo Healthcare Conference & Present at H.C. Wainwright 25th Annual Global Investor Conference
August 29, 2023
Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
August 8, 2023
Equillium Announces $7.5 Million Share Repurchase Program
August 1, 2023
Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences
May 31, 2023
Equillium Reports First Quarter 2023 Financial Results and Provides Clinical Updates
May 10, 2023
Equillium Announces Poster Presentation at the Annual Meeting of the European Society for Blood and Marrow Transplantation
April 23, 2023
Equillium Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate & Clinical Development Updates
March 22, 2023
Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference
March 21, 2023
Equillium Announces Oral Presentation at the Tandem Meetings of ASTCT and CIBMTR
February 16, 2023
Equillium to Present at the SVB Securities Annual Global Healthcare Conference
February 6, 2023
Equillium Announces Abstract Accepted for Oral Presentation at the Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
January 12, 2023
Decks in 2023
- Investor Day (October 2023)
Investor day · 53 slides · Oct 16, 2023
- Investor Presentation (February 2023)
Investor deck · 34 slides · February 2023